+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SAKAR

Sakar Healthcare Share Price

 

 

Sakar Healthcare live price: ₹824.1. It opened at ₹810 vs previous close ₹803; intraday high/low: ₹842/₹810. The 50 & 200 DMA stand at ₹691.08/₹514.32.

Sakar Healthcare Performance

  • Today's Low
  • ₹810
  • Today's High
  • ₹842
  • 52 Week Low
  • ₹306
  • 52 Week High
  • ₹871
  • Open Price₹810
  • Previous Close₹803
  • Volume104,622
  • 50 DMA₹691.08
  • 100 DMA₹605.23
  • 200 DMA₹514.32

Sakar Healthcare Chart

Investment Returns

  • Over 1 Month + 44.67%
  • Over 3 Month + 48.01%
  • Over 6 Month + 95.12%
  • Over 1 Year + 163.63%

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 60.1
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 1,834
  • P/B Ratio
  • 5.7
  • Average True Range
  • 53.57
  • EPS
  • 13.7
  • Dividend Yield
  • 0
  • MACD Signal
  • 49.01
  • RSI
  • 61.29
  • MFI
  • 62.52

Latest Stock News Updates

Sakar Healthcare signs pact with Zydus Lifesciences to supply oncology products across GCC

The company has also submitted 33 site variations across key partners

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹824.10
+ 21.05 (2.62%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹774.50
  • 50 Day
  • ₹691.10
  • 100 Day
  • ₹605.20
  • 200 Day
  • ₹514.30

Resistance and Support

825.2 Pivot Speed
  • R3 871.90
  • R2 856.70
  • R1 840.40
  • S1 808.90
  • S2 793.70
  • S3 777.40

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 251.74 Cr. on a trailing 12-month basis. An annual revenue growth of 42% is outstanding, Pre-tax margin of 16% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 21% and 71% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 49 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-12 Audited results & Others To consider other business matters.
2026-02-05 Quarterly Results & Others To consider other business matters.
2025-11-07 Quarterly Results & Others To consider other business matters.
2025-07-25 Quarterly Results & Others To consider other business matters.
2025-05-15 Audited results

Sakar Healthcare Shareholding Pattern

52.86%
12.94%
18.12%
16.08%

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹824 As on 14 June, 2026 | 20:21

The Market Cap of Sakar Healthcare is ₹1833.6 Cr As on 14 June, 2026 | 20:21

The P/E ratio of Sakar Healthcare is 60.1 As on 14 June, 2026 | 20:21

The PB ratio of Sakar Healthcare is 5.7 As on 14 June, 2026 | 20:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23